Manoj S Nair, etc., al. Serum neutralisation of H5N1 clade 2.3.4.4b influenza is largely mediated by neuraminidase-directed antibodies. The Lancet Microbe
Highly pathogenic avian influenza A (H5N1) continues to circulate globally in avian and mammalian species. Since its emergence in 1997, over 1000 confirmed human infections with H5N1 have been reported, with a case-fatality rate of approximately 50%. In recent years, H5N1 clade 2.3.4.4b viruses have caused extensive outbreaks in wild birds and poultry, resulting in the culling of hundreds of millions of birds. This influenza lineage has also expanded into mammalian hosts, including widespread outbreaks in American dairy cattle and over 70 confirmed human infections in the USA, with two fatalities. The rapid global dissemination and expanding host range of H5N1 clade 2.3.4.4b have raised genuine concerns about its pandemic potential.
See Also:
Latest articles in those days:
- Avian Influenza in Humans: Virology, Transmission, and Clinical Priorities 15 hours ago
- Global influenza epidemiology after 2020: patterns of circulation, epidemic timing and duration, and implications for vaccination strategies 1 days ago
- Coding complete genome of LPAI H16N3 virus from Australia suggests intercontinental movement 2 days ago
- Detection of antibodies to avian influenza virus H5N1 clade 2.3.4.4b in naturally infected cattle for more than a year 2 days ago
- A C-type single-domain antibody with protective efficacy against H1N1 via respiratory administration 2 days ago
[Go Top] [Close Window]


